exagamglogene autotemcel
exagamglogene autotemcel is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including CASGEVY. Available dosage form: injection, suspension.
Drug Details
- Generic Name
- exagamglogene autotemcel
- Brand Names
- CASGEVY
- Application Number
- BLA125787
- Sponsor
- Vertex Pharmaceuticals Incorporated
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SUSPENSION
- Routes
- INTRAVENOUS
- Active Ingredients
- EXAGAMGLOGENE AUTOTEMCEL
Indications and Usage
1. INDICATIONS AND USAGE CASGEVY is indicated for the treatment of patients aged 12 years and older with: sickle cell disease (SCD) with recurrent vaso-occlusive crises transfusion-dependent β - thalassemia (TDT) CASGEVY is an autologous genome edited hematopoietic stem cell-based gene therapy indicated for the treatment of patients aged 12 years and older with: sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs). ( 1 ) transfusion-dependent β-thalassemia (TDT). ( 1 )